Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Bincy P Abraham"'
Publikováno v:
Current Medicine Research and Practice, Vol 11, Iss 3, Pp 113-117 (2021)
Aim: The current research aims to document the prevalence of metabolic syndrome (MetS) and investigate the association between menopausal symptoms and MetS in post-menopausal women. Materials and Methods: A prospective, cross-sectional study was perf
Externí odkaz:
https://doaj.org/article/03d1616252d24733b95be09c5f6989e9
Autor:
Prapaporn Boonma, Jordan M. Shapiro, Emily B. Hollister, Shyam Badu, Qinglong Wu, Erica M. Weidler, Bincy P. Abraham, Sridevi Devaraj, Ruth Ann Luna, James Versalovic, Margaret M. Heitkemper, Tor C. Savidge, Robert J. Shulman
Publikováno v:
Frontiers in Pain Research, Vol 2 (2021)
Background: Little is known regarding the clinical impact of treatment and treatment duration of probiotic VSL#3 on gut and microbiome function in irritable bowel syndrome (IBS). As part of a safety trial, we assessed the effect of VSL#3 treatment du
Externí odkaz:
https://doaj.org/article/b17dc45b76f14cabbd64631563111740
Publikováno v:
Clinical and Experimental Gastroenterology. 16:21-28
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf52290054a2babc531c969c80ed0a97
https://doi.org/10.2147/ceg.s367086
https://doi.org/10.2147/ceg.s367086
Autor:
Adam Saleh, Bincy P Abraham
Publikováno v:
Crohn's & Colitis 360.
Background There is a clinical need to improve monitoring of inflammatory bowel disease (IBD) disease activity. Despite being used regularly in European countries, intestinal ultrasound (IUS) has been implemented less in the United States for unclear
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::939e16b8bfdafbb778a1105d8b8951c1
https://doi.org/10.1093/crocol/otad027
https://doi.org/10.1093/crocol/otad027
Publikováno v:
Digestive Diseases.
Background: Considerable research supports an important role for the microbiome and/or microbiome–host immune system interactions in the pathogenesis of inflammatory bowel disease (IBD). Consequently, microbiota-modulating interventions, such as fe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1b37e869a577ad0f60dec1e78b7ffa63
https://doi.org/10.1159/000529591
https://doi.org/10.1159/000529591
Autor:
Konstantinos, Papamichael, Niels, Vande Casteele, Bincy P, Abraham, Timothy, Ritter, Anjali, Jain, Adam S, Cheifetz
Publikováno v:
Clinical Gastroenterology and Hepatology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5308664961a6ab66bcc986111d437a8a
https://doi.org/10.1016/j.cgh.2022.10.037
https://doi.org/10.1016/j.cgh.2022.10.037
Autor:
Bincy P Abraham, Elyssa Ott, Christopher Busse, Conor Murphy, Lindsay Miller, Daniel C Baumgart, Ellen Scherl, Christopher Gasink
Publikováno v:
Crohn's & Colitis 360. 4
Background While no adverse developmental outcomes were observed in preclinical animal studies, limited data exist regarding effects of ustekinumab on human pregnancies. Previously, no data have been reported for women treated with ustekinumab in inf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::65f6ca0aae71765d5d6c19bbba102ba0
https://doi.org/10.1093/crocol/otac025
https://doi.org/10.1093/crocol/otac025
Autor:
Pramoda Koduru, Bincy P. Abraham
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 9 (2016)
Iron deficiency anemia (IDA) is the most common form of nutritional anemia worldwide. Iron plays a pivotal role in vital functioning of almost every organ system. IDA affects both physical and psychological functioning of humans. Oral iron is conside
Externí odkaz:
https://doaj.org/article/f820a4f41856490e86194004ced7d252
Publikováno v:
Biologics : targetstherapy. 16
Several biologic therapies have been approved for enteric diseases. We evaluate each biologic's role based on their mechanism of action in treating these conditions. This review examines data on efficacy and safety, as well as considerations for usin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2eb0303e2d4446f130efe09ae78b8dde
https://pubmed.ncbi.nlm.nih.gov/35747234
https://pubmed.ncbi.nlm.nih.gov/35747234
Autor:
Quazim A Alayo, Marc Fenster, Osama Altayar, Kerri L Glassner, Ernesto Llano, Kindra Clark-Snustad, Anish Patel, Lukasz Kwapisz, Andres J Yarur, Benjamin L Cohen, Matthew A Ciorba, Deborah Thomas, Scott D Lee, Edward V Loftus, David I Fudman, Bincy P Abraham, Jean-Frederic Colombel, Parakkal Deepak
Publikováno v:
Crohn's & Colitis 360. 4
Background Combining biologics and small molecules could potentially overcome the plateau of drug efficacy in inflammatory bowel disease (IBD). We conducted a systematic review and meta-analysis to assess the safety and effectiveness of dual biologic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2bbc654b152cb33efb3cd41f659f407
https://doi.org/10.1093/crocol/otac002
https://doi.org/10.1093/crocol/otac002